An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone posted that before jumping into hormone or peptide treatments, people should test their IGF-1 level first. They got their own result back: 253 (units not given, but that’s their lab number). The note is aimed at people debating things like IPA, IGF-1 LR3, or HGH—different ways people try to boost growth signals—and it’s a reminder to know your starting point before deciding to take anything. IGF-1 stands for insulin-like growth factor 1. It’s a hormone made mostly in the liver in response to growth hormone (HGH). Think of it as one of the body’s “growth signals” that helps tissues repair and grow. There are lab tests that measure blood IGF-1, and doctors sometimes use that number to judge whether someone has too little or too much growth signaling. IGF-1 LR3 and IPA are synthetic peptides or modified versions people talk about online; HGH is the natural hormone often prescribed for clear medical conditions. They’re all aimed at increasing that growth signal, but they work differently and have different legal and safety profiles. The important research and clinical practice point here is that IGF-1 testing gives you context. The post is not a study but practical advice: before adding something that raises IGF-1, measure it. That person’s level of 253 is a single data point; without reference ranges from the lab, age, sex, or symptoms, it’s hard to interpret. In many labs, “normal” IGF-1 ranges vary by age and lab method. Clinical decisions about starting HGH or peptides typically rely on patterns of symptoms, repeated tests, and a doctor’s evaluation—not one number alone. There’s no claim here about treatment effects, just that a baseline test is a useful first step. Why this matters is simple: these drugs and peptides can change your body in big ways. If your IGF-1 is already in a normal or high range, taking something to boost it further may be unnecessary or harmful. People trying to optimize fitness, anti-aging, or recovery are especially tempted by online advice. Getting a baseline test helps you and your clinician decide if a treatment might address a real deficiency or just chase a number. It can also prevent spending money and taking risks on something you don’t need. Caveats and risks: IGF-1 levels fluctuate with age, nutrition, and illness, so a single test can be misleading. Lab reference ranges differ, so you need the lab’s attached “normal” range and a doctor to interpret it. Increasing IGF-1 with HGH or peptides can cause side effects: fluid retention, joint pain, insulin resistance, elevated blood sugar, and, in some cases, increased cancer risk is a theoretical concern because IGF-1 promotes cell growth. Many peptides sold online are unregulated and of uncertain purity. Only prescribed HGH for approved medical conditions is legal and monitored; using it otherwise can be risky and illegal in some places. Bottom line: Get your IGF-1 tested before experimenting—know your baseline and consult a clinician so you don’t treat a problem you don’t have.
Source: r/Peptides